Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06223711 |
| Title | Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Universitat des Saarlandes |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University Hospital Augsburg, Radiation Oncology | RECRUITING | Augsburg | Bavaria | 86156 | Germany | Details |
| University Hospital Erlangen, Radiation Oncology | RECRUITING | Erlangen | Bavaria | 91054 | Germany | Details |
| University Hospital Regensburg, Clinic and Polyclinic for Radiotherapy | RECRUITING | Regensburg | Bavaria | 93053 | Germany | Details |
| Kliniken Maria Hilf | RECRUITING | Mönchengladbach | NRW | 41063 | Germany | Details |
| Saarland University Medical Center and Saarland University Faculty of Medicine, Clinic for Radiotherapy and Radiooncology | RECRUITING | Homburg | Saarland | 66421 | Germany | Details |